We showed that combined administration of RvE1 and LXA4 could effectively promote pulpitis resolution by inhibiting NF‐κB activation via upregulation of SIRT7 expression, reducing expression of pro‐inflammatory factors. This evidence concerns the gene SIRT7 and pulpitis.